New study aims to boost colon cancer detection in native communities
NCT ID NCT07515729
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study focuses on American Indian communities, who face high colorectal cancer death rates. Researchers will test a program where a navigator helps clinics and patients schedule diagnostic colonoscopies within 60 days after a positive screening. The goal is to improve early detection and reduce health disparities.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Navigator-led intervention
- What this could lead to
- If successful, this could increase early detection of colorectal cancer in American Indian communities, potentially reducing high mortality rates.
- What could go wrong
- This is a relatively small, early-stage implementation study, so results may not apply broadly. Success depends on clinic and patient participation, which can be unpredictable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER (CRC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Why are more younger adults getting colorectal cancer? a national study digs into the data
- New drug combo aims to boost response in Hard-to-Treat colorectal cancer
- First-in-Class cancer drug targets Hard-to-Treat tumors
- New pill targets Hard-to-Treat cancers with a specific gene mutation
- AI eye on cancer: robot helps spot hidden polyps
- New hope for Hard-to-Treat colorectal cancer? drug combo trial launches